Arcus Biosciences Inc (RCUS)
15.50
+0.82
(+5.62%)
USD |
NYSE |
Apr 23, 16:00
15.50
0.00 (0.00%)
After-Hours: 18:24
Arcus Biosciences Total Liabilities (Quarterly): 633.00M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 633.00M |
| September 30, 2023 | 671.00M |
| June 30, 2023 | 654.00M |
| March 31, 2023 | 654.00M |
| December 31, 2022 | 688.00M |
| September 30, 2022 | 695.12M |
| June 30, 2022 | 729.39M |
| March 31, 2022 | 746.85M |
| December 31, 2021 | 750.00M |
| September 30, 2021 | 296.68M |
| June 30, 2021 | 294.22M |
| March 31, 2021 | 270.33M |
| December 31, 2020 | 269.99M |
| Date | Value |
|---|---|
| September 30, 2020 | 266.66M |
| June 30, 2020 | 52.68M |
| March 31, 2020 | 35.51M |
| December 31, 2019 | 39.27M |
| September 30, 2019 | 39.73M |
| June 30, 2019 | 42.33M |
| March 31, 2019 | 36.96M |
| December 31, 2018 | 39.98M |
| September 30, 2018 | 41.60M |
| June 30, 2018 | 39.29M |
| March 31, 2018 | 38.81M |
| December 31, 2017 | 36.62M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
35.51M
Minimum
Mar 2020
750.00M
Maximum
Dec 2021
412.04M
Average
296.68M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences Inc | 39.38B |
| Catalyst Pharmaceuticals Inc | 82.23M |
| Integra Lifesciences Holdings Corp | 2.194B |
| Palatin Technologies Inc | 24.94M |
| Petros Pharmaceuticals Inc | 21.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.095B |
| Shareholders Equity (Quarterly) | 462.00M |
| Current Ratio | 4.516 |